The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice

Pharmacological Reports

Volumn 67, Issue 6, 2015, Pages 1155-1162

  Sałat, Kinga ^a   Podkowa, Adrian ^a   Mogilski, Szczepan ^a   Zaręba, Paula ^a   Kulig, Katarzyna ^a   Sałat, Robert ^b   Malikowska, Natalia ^a   Filipek, Barbara ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Fear motivated memory; GABA transporter 1 (GAT1); Scopolamine induced memory deficits; Spatial memory; Tiagabine

Indexed keywords

SCOPOLAMINE; TIAGABINE; 4 AMINOBUTYRIC ACID UPTAKE INHIBITOR; NIPECOTIC ACID DERIVATIVE; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; LEARNING; MALE; MEMORY; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE TEST; RADIAL ARM MAZE TEST; SCOPOLAMINE-INDUCED COGNITIVE DEFECT; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DRUG EFFECTS; MAZE TEST; MEMORY DISORDERS; RECALL;

ANIMALS; AVOIDANCE LEARNING; GABA UPTAKE INHIBITORS; MALE; MAZE LEARNING; MEMORY DISORDERS; MENTAL RECALL; MICE; NIPECOTIC ACIDS; SCOPOLAMINE HYDROBROMIDE;

EID: 84936955146     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.04.018     Document Type: Article

References (49)

1. A. Schousboe, K.K. Madsen, M.L. Barker-Haliski, and H.S. White The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters Neurochem Res 39 10 2014 1980 1987
2. F. Conti, A. Minelli, and M. Melone GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications Brain Res Brain Res Rev 45 3 2004 136 212
3. K. Sałat, and K. Kulig GABA transporters as targets for new drugs Future Med Chem 3 2 2011 211 222
4. A. Schousboe, A. Sarup, O.M. Larsson, and H.S. White GABA transporters as drug targets for modulation of GABAergic activity Biochem Pharmacol 68 8 2004 1557 1563
5. X. Zhao, J. Pabel, G.C. Höfner, and K.T. Wanner Synthesis and biological evaluation of 4-hydroxy-4-(4-methoxyphenyl)-substituted proline and pyrrolidin-2-ylacetic acid derivatives as GABA uptake inhibitors Bioorg Med Chem 21 2 2013 470 484
6. N.O. Dalby Inhibition of gamma-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures Eur J Pharmacol 479 1-3 2003 127 137
7. I. Sitka, L. Allmendinger, G. Fülep, G. Höfner, and K.T. Wanner Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors Eur J Med Chem 65 2013 487 489
8. G. Quandt, G. Höfner, J. Pabel, J. Dine, M. Eder, and K.T. Wanner First photoswitchable neurotransmitter transporter inhibitor: light-induced control of γ-aminobutyric acid transporter 1 (GAT1) activity in mouse brain J Med Chem 57 15 2014 6809 6821
9. K. Sałat, K. Kulig, R. Sałat, B. Filipek, and B. Malawska Analgesic and anticonvulsant activity of new derivatives of 2-substituted 4-hydroxybutanamides in mice Pharmacol Rep 64 1 2012 102 112
10. K. Sałat, A. Więckowska, K. Więckowski, G.C. Höfner, J. Kamiński, K.T. Wanner, and et al. Synthesis and pharmacological properties of new GABA uptake inhibitors Pharmacol Rep 64 4 2012 817 833
11. P. Kowalczyk, K. Sałat, G.C. Höfner, N. Guzior, B. Filipek, K.T. Wanner, and et al. 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation Bioorg Med Chem 21 17 2013 5154 5167
12. P. Kowalczyk, K. Sałat, G.C. Höfner, M. Mucha, A. Rapacz, A. Podkowa, and et al. Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides Eur J Med Chem 83 2014 256 273
13. B. Kragholm, T. Kvist, K.K. Madsen, L. Jørgensen, S.B. Vogensen, A. Schousboe, and et al. Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile Biochem Pharmacol 86 4 2013 521 528
14. J. Pabel, M. Faust, C. Prehn, B. Wörlein, L. Allmendinger, G. Höfner, and et al. Development of an (S)-1-{2-[tris(4-methoxyphenyl)methoxy]ethyl}piperidine-3-carboxylic acid [(S)-SNAP-5114] carba analogue inhibitor for murine γ-aminobutyric acid transporter type 4 ChemMedChem 7 7 2012 1245 1255
15. K. Sałat, A. Podkowa, P. Kowalczyk, K. Kulig, A. Dziubina, B. Filipek, and et al. Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression Pharmacol Rep 67 2015 465 472
16. C.K. Thoeringer, A. Erhardt, I. Sillaber, M.B. Mueller, F. Ohl, F. Holsboer, and et al. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice J Psychopharmacol 24 5 2010 733 743
17. L.L. Carpenter, J.M. Schecter, A.R. Tyrka, A.F. Mello, M.F. Mello, R. Haggarty, and et al. Open-label tiagabine monotherapy for major depressive disorder with anxiety J Clin Psychiatry 67 1 2006 66 71
18. V. Novak, R. Kanard, J.T. Kissel, and J.R. Mendell Treatment of painful sensory neuropathy with tiagabine: a pilot study Clin Auton Res 11 6 2001 357 366
19. M.H. Pollack, P.P. Roy-Byrne, M. Van Ameringen, H. Snyder, C. Brown, J. Ondrasik, and et al. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study J Clin Psychiatry 66 11 2005 1401 1408
20. T.L. Schwartz, and N. Nihalani Tiagabine in anxiety disorders Expert Opin Pharmacother 7 14 2006 1977 1987
21. A.A. Todorov, C.B. Kolchev, and A.B. Todorov Tiagabine and gabapentin for the management of chronic pain Clin J Pain 21 4 2005 358 361
22. N. Fritz, S. Glogau, J. Hoffmann, M. Rademacher, C.E. Elger, and C. Helmstaedter Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy Epilepsy Behav 6 3 2005 373 381
23. P. Ortinski, and K.J. Meador Cognitive side effects of antiepileptic drugs Epilepsy Behav 5 Suppl. 1 2004 60 65
24. T. Myhrer Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks Brain Res Brain Res Rev 41 2-3 2003 268 287
25. C. Castellano, A. Zocchi, S. Cabib, and S. Puglisi-Allegra Psychopharmacology of memory modulation: evidence for multiple interaction among neurotransmitters and hormones Behav Brain Res 77 1996 1 21
26. N. Collinson, F.M. Kuenzi, W. Jarolimek, K.A. Maubach, R. Cothliff, C. Sur, and et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor J Neurosci 22 13 2002 5572 5580
27. J. Shi, Y. Cai, G. Liu, N. Gong, Z. Liu, T. Xu, and et al. Enhanced learning and memory in GAT1 heterozygous mice Acta Biochim Biophys Sin 44 4 2012 359 366
28. R. Tellez, L. Gómez-Víquez, and A. Meneses GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia Neurobiol Learn Mem 97 2 2012 189 201
29. P. Kwan, and M.J. Brodie Neuropsychological effects of epilepsy and antiepileptic drugs Lancet 357 9251 2001 216 222
30. U. Schmitt, and C. Hiemke Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze Behav Brain Res 133 2 2002 391 394
31. I. Klinkenberg, and A. Blokland The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies Neurosci Biobehav Rev 34 8 2010 1307 1350
32. S.S. Patil, B. Sunyer, H. Höger, and G. Lubec Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze Behav Brain Res 198 1 2009 58 68
33. S.J. Park, D.H. Kim, J.M. Jung, J.M. Kim, M. Cai, X. Liu, and et al. The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice Eur J Pharmacol 676 1-3 2012 64 70
34. D. Puzzo, L. Lee, A. Palmeri, G. Calabrese, and O. Arancio Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines Biochem Pharmacol 88 4 2014 450 467
35. I. Bialuk, K. Dobosz, B. Potrzebowski, and M.M. Winnicka CP55,940 attenuates spatial memory retrieval in mice Pharmacol Rep 66 6 2014 931 936
36. J. Alamed, D.M. Wilcock, D.M. Diamond, M.N. Gordon, and D. Morgan Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice Nat Protoc 1 4 2006 1671 1679
37. D.M. Wilcock, A. Rojiani, A. Rosenthal, S. Subbarao, M.J. Freeman, M.N. Gordon, and et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage J Neuroinflamm 1 1 2004 24
38. T.L. Sudduth, E.M. Weekman, H.M. Brothers, K. Braun, and D.M. Wilcock β-Amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice Alzheimers Res Ther 6 3 2014 32
39. Y. Wang, H. Kan, Y. Yin, W. Wu, W. Hu, M. Wang, and et al. Protective effects of ginsenoside Rg1 on chronic restraint stress induced learning and memory impairments in male mice Pharmacol Biochem Behav 120 2014 73 81
40. R. Sankar, and G.L. Holmes Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects J Child Neurol 19 Suppl. 1 2004 S6 S14
41. M. Mula, and M.R. Trimble Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors CNS Drugs 23 2 2009 121 137
42. D.D. Ferreira, B. Stutz, F.G. de Mello, R.A. Reis, and R.C. Kubrusly Caffeine potentiates the release of GABA mediated by NMDA receptor activation: Involvement of A1 adenosine receptors Neuroscience 281C 2014 208 215
43. A.W. O'Connell, G.B. Fox, C. Kjøller, H.C. Gallagher, K.J. Murphy, J. Kelly, and et al. Anti-ischemic and cognition-enhancing properties of NNC-711, a gamma-aminobutyric acid reuptake inhibitor Eur J Pharmacol 424 1 2001 37 44
44. N. Gong, Y. Li, G.Q. Cai, R.F. Niu, Q. Fang, K. Wu, and et al. GABA transporter-1 activity modulates hippocampal theta oscillation and theta burst stimulation-induced long-term potentiation J Neurosci 29 50 2009 15836 15845
45. J.H. Hu, Y.H. Ma, J. Jiang, N. Yang, S.H. Duan, Z.H. Jiang, and et al. Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1) Neuroreport 15 1 2004 9 12
46. H.O. Gulcan, S. Unlu, I. Esiringu, T. Ercetin, Y. Sahin, D. Oz, and et al. Design, synthesis and biological evaluation of novel 6H-benzo[c]chromen-6-one, and 7,8,9,10-tetrahydro-benzo[c]chromen-6-one derivatives as potential cholinesterase inhibitors Bioorg Med Chem 22 19 2014 5141 5154
47. C.M. Paul, G. Magda, and S. Abel Spatial memory: theoretical basis and comparative review on experimental methods in rodents Behav Brain Res 203 2 2009 151 164
48. R. D'Hooge, and P.P. De Deyn Applications of the Morris water maze in the study of learning and memory Brain Res Brain Res Rev 36 1 2001 60 90
49. S. Sharma, S. Rakoczy, and H. Brown-Borg Assessment of spatial memory in mice Life Sci 87 17-18 2010 521 536